Oxbryta Medication Recall for Sickle Cell Disease

In September 2024, Pfizer Inc. published a press release announcing it voluntarily recalled all Oxbryta (Voxelotor). Oxbryta was used to treat sickle cell disease and was once thought of as a breakthrough treatment for the deadly disorder.

The following day, the United States Food & Drug Administration (FDA) published a safety alert regarding Pfizer’s recall. It recommended that healthcare providers stop prescribing the drug and that patients contact their doctors. The FDA’s safety alert explained that Oxbryta was recalled because of severe adverse side effects in Oxbryta treatment groups relative to controls.

You may be entitled to compensation if you experienced severe adverse reactions after taking Pfizer’s Oxbryta. Contact the experienced defective drug lawyers at The Yost Legal Group today for a free consultation regarding your claim. We are available by phone or text at 410-659-6800.

Severe Side Effects From Sickle Cell Medication Oxbryta

Oxbryta Recall Linked to Vaso-Occlusive Crises – Find the Facts

Two FDA-mandated studies have revealed a concerning risk associated with Oxbryta. Research shows that Oxbryta may increase the likelihood of experiencing a life-threatening vaso-occlusive crisis, a condition that can result in organ failure, stroke, or even death.

Following these findings, the FDA has concluded that the risks of Oxbryta outweigh its benefits. Symptoms of vaso-occlusive crisis may include:

  • Fever
  • Pain
  • Swelling
  • Kidney Failure
  • Stroke
  • Death

If you or a loved one have taken Oxbryta and suffered severe side effects, it’s important to act now. Consult your healthcare professional and contact our product liability lawyers for guidance.

Our experienced product liability attorneys are ready to help you understand if you qualify to join the Oxbryta lawsuit.

stroke from Oxbryta medication for treating sickle cell anemia

The Benefit of Pfizer Sickle Cell Drug “No Longer Outweighs the Risk”

Pfizer, a multinational biopharmaceutical giant valued at over $140 billion, markets itself as “one of the world’s premier biopharmaceutical companies.” With such immense resources, it’s no surprise that Pfizer has a legal team to match its stature, prepared to defend the company at all costs.

But what about the individuals harmed by Big Pharma’s actions? If you’ve been negatively impacted, you need an experienced, compassionate, and relentless legal team—someone who will stand up to billion-dollar corporations and fight for justice on your behalf.

At The Yost Legal Group, we’ve advocated for ordinary people for over 35 years. Our defective drug attorneys have fought—and won—against some of the largest pharmaceutical companies for our clients, ensuring they receive the justice they deserve.

Pfizer prioritized profits over safety, putting lives at risk to fast-track its drug. It’s time to hold the drug manufacturers accountable. Contact The Yost Legal Group today for a free consultation.

Oxbryta lawsuit for sickle cell patients

What Is Sickle Cell Disease?

The recalled drug Oxbryta is the brand name of Voxelotor, a medication used to treat sickle cell disease (SCD). SCD is a group of blood disorders that affect the hemoglobin. You might be most familiar with sickle cell disease, which is known as sickle cell anemia.

This is all very technical and heavy on medical terminology, so we will go through each portion piece by piece.

First, we will discuss hemoglobin: It is easy to think of blood as just one substance, a bodily fluid that flows through all of us. But blood comprises many other substances, such as nutrients and oxygen. There are red blood cells. There are white blood cells.

In red blood cells, a protein rich in iron called hemoglobin facilitates the transportation of oxygen from the respiratory organs (lungs or gills) to the body’s other tissues.

However, due to a gene mutation, sickle cell disease occurs when a person inherits two abnormal copies (one from each parent) of the gene that makes hemoglobin. The red blood cells adopt an abnormal sickle-like shape, giving the disorder group its name.

These misshapen red blood cells cause many health issues, such as anemia, bacterial infections, and capillary blockages. Furthermore, all of the significant organs suffer as these deformed red blood cells pass through the body, causing attacks of pain known as “sickle cell crisis.”

Sickle cell disease is a life-long disorder that is often fatal. Without treatment, people with SCD rarely reach adulthood. Even with treatment, though people reach adulthood and even middle age, their life expectancy is significantly lower than that of people without the disease.

What Is the Medication Oxbryta (Voxelotor)?

Oxbryta was an oral medication. Patients were meant to take one tablet daily. Its intended use was for the treatment of sickle cell disease, the hemoglobin-related blood disorder that is, at best, degenerative and, at worst, fatal even before a person reaches adulthood.

As SCD affects the shape of red blood cells and limits hemoglobin’s ability to carry oxygen from the lungs to other parts of the body, Oxbryta was developed to increase hemoglobin’s affinity for oxygen.

In November 2019, Global Blood Therapeutics (a subsidiary of Pfizer since October 2022), received an accelerated approval from the FDA for Voxelotor as a treatment for SCD patients 12 years and older, making it the first hemoglobin oxygen-affinity modulator.

It was the first drug to target the root cause of SCD. This approval was a landmark win in a long and difficult battle against the disease.

In December 2021, the FDA again granted Global Blood Therapeutics an accelerated approval for the prescription drug Voxelotor in sickle c patients between the ages of four and 11.

However, the actual results of the trials were not so conclusive.

Oxbryta Medication Recalled by the FDA

On September 25, 2024, Pfizer, the parent company of Global Blood Therapeutics, the original developer of Voxelotor for nearly two years, withdrew all lots of Oxbryta from worldwide markets.

This recall sent shockwaves through the SCD community five years after the initial breakthrough approval. “Clinicians and patients were shocked to hear that the drug was being withdrawn from the market because of safety concerns.”

According to Pfizer’s own press release:

“Pfizer’s decision is based on the totality of clinical data that now indicates the overall benefit of OXBRYTA no longer outweighs the risk in the approved sickle cell patient population. The data suggests an imbalance in vaso-occlusive crises and fatal events which require further assessment.”

Despite this, many clinicians were still left with more questions as Pfizer did not provide many details to support its claims: “Specifically, the letter noted that the decision was based on the ‘totality of clinical data,’ but did not provide any details on adverse events.”

Charles Abrams, MD, the Francis C. Wood professor of medicine at the University of Pennsylvania School of Medicine, used the opportunity to call into question the FDA’s accelerated approval pathway:

“[Accelerated approval] has always been a double-edged sword. Certainly, it accomplished the idea of getting drugs out there and utilized more quickly. Some drugs that have been approved through this pathway have later been proved to be ineffective and sometimes even unsafe for patients.”

In the intervening time, the European Medicines Agency (EMA) has also recommended the suspension of Oxbryta based on new data from a study that has been ongoing since July 2024.

Injured by Oxbryta? Call for Free Legal Help Today!

Similar to Pfizer, the EMA cited an increase in vaso-occlusive crises in patients taking Oxbryta compared to before they started the treatment.

There is still much to learn, but it is clear that Pfizer had a dangerous drug on the market for about five years. If you have been prescribed Oxbryta, consult with your healthcare professional to discuss a plan for getting off the recalled drug.

If the use of Oxbryta, the sickle cell anemia drug, has harmed you or a loved one, you may have a case. Call the experienced defective drug lawyers at The Yost Legal Group for a free consultation. We are available by phone or text at 410-659-6800 or toll-free at 1-800-659-6800.

When your health and safety are on the line, there is no time to delay. Contact an Oxbryta lawyer who will fight for your rights and help you get the justice you deserve.

Sickle Cell Disease Crisis – Hemoglobin C Disease – Sickle Cell Disease Cause

Oxbryta Side Effects – Oxbryta Death Claim – Oxbryta Claim – Dangerous Drug Lawyers

FDA Announces Voluntary Clonazepam Recall

The Benzodiazepine, a Generic Form of Klonopin, Had a “Life-Threatening” Labeling Error

A vital safety alert was issued for Clonazepam users. Endo, Inc., a pharmaceutical company based in Pennsylvania, has recalled its seizure medication, Clonazepam tablets.

The recall is due to a mistake in labeling the product strength on the carton. Such a serious error could lead to life-threatening consequences for thousands of users.

The recall is part of an FDA investigation. Endo, Inc. expanded its initial voluntary recall from July 16. The FDA announced the expanded recall in an alert on Nov. 19.

Clonazepam pillss recalled from the market

Urgent Warning for Clonazepam Users—Verify Your Dose Now

If you use clonazepam benzodiazepine, check your product’s labeling immediately. People who take a higher dose of Clonazepam could face serious health risks, including:

–      Extreme drowsiness

–      Confusion

–      Dizziness

–      Slowed reflexes

–      Lack of coordination

–      Low muscle tone

–      Life-threatening respiratory depression

There is a significant chance of life-threatening respiratory depression:

  • Particularly for individuals with lung conditions
  • Those already prescribed high doses of Clonazepam
  • Patients taking other medications that suppress breathing

If you have experienced a severe adverse reaction from Clonazepam, contact 1-800-967-8529 for a 100% Free and Confidential consultation. The Yost Legal Group is a highly experienced Product Liability law firm. Our Clonazepam lawyers will investigate what happened and fight to seek the justice and financial compensation you deserve.

 Clonazepam can cause adverse reactions

What Is Clonazepam?

The drug Clonazepam is a generic drug under the benzodiazepine class of depressant drugs.

Depressants: These types of drugs affect the brain’s activity. They slow neurotransmission levels and decrease electrical activity in the brain. Depressants also inhibit an individual’s ability to feel arousal and stimulation.

This reduction in brain activity is why depressant drugs can be effective when used correctly. A medical professional prescribes them to relieve disorders and symptoms such as:

  • Anxiety disorders
  • Depression
  • Insomnia
  • Obsessive-compulsive disorder
  • Seizures

Alcohol, benzodiazepines, and cannabis are some of the most common types of depressant drugs.

Benzodiazepines: Benzodiazepines, known as “benzos,” are a class of depressant drugs. This type of drug derives its name from its chemical compound, which is a fusion of benzene and diazepine rings.

Medically, benzodiazepines are most often used to treat anxiety and panic disorders, insomnia, and seizures. Common types of benzodiazepines include alprazolam (Xanax®), clonazepam (Klonopin®), and diazepam (Valium®).

Clonazepam is a generic benzodiazepine sold under the brand name Klonopin®, which more people are probably familiar with. This recall, however, pertains only to the generic version.

Clonazepam side effects, file a Clonazepam lawsuit

Severe Health Risks Linked to Incorrect Clonazepam Dosage

Clonazepam is often used to treat anxiety disorders, bipolar mania, and seizures. Anyone with these ailments and conditions needs regular help. For some people, it might be difficult to make it through a day without their prescribed medication.

Pharmaceutical companies have a clear duty to ensure their products are safe. This includes items people apply, ingest, or inject. They must also make sure their product labels are accurate. These labels tell people how to use their medications safely.

The recall for Clonazepam relates to the tablet version, as the drug is most often taken orally.

The packaging had a labeling mistake. The company said it was “possibly life-threatening.” This was also noted in the FDA safety warning. If a user took the wrong amount of the medication, it could be dangerous. This happened because the number of milligrams in each tablet was incorrect.

If you or someone you know may have been affected, seek medical attention immediately. Contact The Yost Legal Group’s “Dangerous Drugs” division to learn about your legal rights.

Life-Threatening Clonazepam Risks—Know Your Legal Rights

This was no small mistake. In 1960, Clonazepam was patented and became available in the United States in 1975. Doctors have prescribed the drug often since it has been on the market for decades.

According to ClinCalc.com, Clonazepam was the 57th most prescribed drug in the United States in 2022. More than 11.5 million prescriptions of Clonazepam were made out to nearly 2 million patients in 2022.

This mislabeling put millions of people at risk. Furthermore, it was not the first time Endo was derelict in its duties regarding labeling its clonazepam packaging.

The product recall focuses on Clonazepam drug side effects, one of which can result in death from Clonazepam. The product liability lawyers at The Yost Legal Group are here to help. Many FDA recalls exist; the highest level occurs when the FDA issues an FDA Black Boxed Warning. This usually happens when a company is about to remove a drug from the market.

The First Clonazepam Recall of 2024

On July 17, 2024, the FDA published a safety alert that it voluntarily recalled many orally disintegrating drugs due to mislabeling.

Endo announced that the lot it was recalling included packaging that under-reported the strength of each tablet:

“The product lot [550147301] is being recalled due to mislabeling where an incorrect strength appears on the cartons of some packs to show the product strength as 0.125 mg and not 0.25 mg due to an error at a third-party packager.”

Regardless of the mistake by the “third-party packager,” Endo bears responsibility as the drug manufacturer and the employer of the company that packages its medication.

However, it was just one lot and one recall. As Endo noted in its statement, “to date [the company] has not received any reports of adverse events associated with this product lot recall.”

But it would not remain just one lot and one recall for much longer.

If a defective drug harmed you or a loved one, you may have a case and be entitled to compensation. Call or text the experienced defective drug lawyers at The Yost Legal Group today for a free consultation: 410-659-6800.

The Second Clonazepam Recall of 2024

As previously stated, Endo voluntarily recalled Clonazepam in November 2024, and the FDA ran a safety alert. The second recall, however, was not just to announce the recall of a second lot. The alert included a whopping 16 lots of the drug.

The table below includes the product description (Clonazepam Orally Disintegrating Tablets), the National Drug Code number, and the lot number.

Potential Product Description / NDC Number  Lot Number Expiry Date

Clonazepam ODT, USP (C-IV) 2mg / 49884-310-02 550176501 Feb 2027

550176601 Feb 2027

Clonazepam ODT, USP (C-IV) 0.125mg / 49884-306-02 550174101 Jan 2027

Clonazepam ODT, USP (C-IV) 0.25mg / 49884-307-02 550142801 Aug 2026

550142901 Aug 2026

550143001 Aug 2026

550143101 Aug 2026

550143201 Aug 2026

550143301 Aug 2026

550143401 Aug 2026

550147201 Aug 2026

550147401 Aug 2026

Clonazepam ODT, USP (C-IV) 1mg / 49884-309-02 550145201 Aug 2026

550175901 Feb 2027

550176001 Feb 2027

550176201 Feb 2027

Again, Endo placed the blame on its third-party packager:

“Endo’s ongoing investigation has identified the possibility that the Clonazepam product lots listed below contain a limited number of cartons printed with the incorrect strength and National Drug Code (NDC) code due to an error by a third-party packager.”

Serious Side Effects from Clonazepam? We Can Help

Endo is responsible for its medication, and for the third-party packager/s, it hires to label its products. Although the actual medication is not defective, it is still vital to ensure the labeling is correct so that people using the drug can do so safely.

This repeat of negligence with mislabeling puts real people at risk. As of 2022, nearly 2 million people were prescribed Clonazepam, and now there are 16 recalled lots. Endo put its customers in harm’s way.

We do not know how the packages got the wrong information. However, we have seen how small details can be missed at big pharmaceutical companies. Some companies cut corners to save money, which harms people. The result is almost always putting innocent people at risk.

Clonazepam Adverse Reaction? Seek Justice Today

The Yost Legal Group has a long history of representing individuals and their families after a defective drug altered someone’s life.

Drug companies are billion-dollar multinational corporations with some of the best pharmaceutical lawyers in the world. A skilled and experienced defective drug lawyer must handle the complex legal issues when suing a Big Pharma company.

That is where The Yost Legal Group’s accomplished defective drug lawyers factor into the equation. As leading personal injury attorneys, we file product liability lawsuits every day. Let us file your Clonazepam claim.

Many cases involve prescription drugs because of “failure to warn” and “serious pharmaceutical side effects.”

If a defective drug has harmed you or a loved one, please get in touch with The Yost Legal Group today. Our defective drug lawyers will start working on your case right away. They will help you understand your rights to seek the compensation and justice you deserve. Call or text us at 410-659-6800.

All consultations are free, and you do not owe us anything unless we take on and win your case.

Defective Products Lawyers – Defective Products Law Firm – Products Liability Attorneys

Products Liability Attorney Recall – Clonazepam Warnings –

Depo Provera Lawsuit

A new study raises concerns about the potential link between Depo-Provera® contraceptive injections and meningioma brain tumors. Research suggests women who have used Depo-Provera® long-term may face an increased risk of developing this condition. Do you qualify to file a Depo Provera lawsuit?

If you or someone you love has been diagnosed with a meningioma after using Depo-Provera®, you may qualify to file a Depo Provera lawsuit. Let us help you seek the justice and financial compensation you deserve.

Contact The Yost Legal Group today at 800-967-8529 for a free consultation. Our experienced Depo attorneys are ready to help you explore your legal options. Don’t wait—call now.

brain mass meningioma side effects from depo birth control shot

Know Your Rights After Depo-Provera Meningiomas Diagnosis

  • Prolonged Use of Depo-Provera® May Increase Risk of Brain Tumors
  • Recent research highlights an important concern for women using Depo-Provera® as a contraceptive. Studies have shown that extended use of Depo-Provera® significantly increases the risk of developing meningioma, a type of brain tumor.
  • 5.6x Higher Risk with Depo-Provera Women who use Depo-Provera® for more than one year face a 5.6-times higher risk of developing meningiomas, according to a study in the British Medical Journal. If you’ve experienced health complications linked to Depo-Provera®, seek guidance today.
  • Meningiomas May Require Surgical Treatment – Meningiomas are tumors that can grow and put dangerous pressure on the brain. These growths often demand invasive surgery, which comes with serious health risks and potential complications. If you or a loved one are facing a diagnosis, consult a healthcare specialist immediately for guidance and treatment options. Early intervention is critical.
  • Common Symptoms of Meningioma: Persistent headaches, vision issues, seizures, hearing loss, or weakness in the limbs could be symptoms of a meningioma—a type of brain tumor. These signs should not be ignored. If you’re experiencing any of these symptoms, consult a healthcare professional immediately for evaluation. Early detection can make all the difference.
  • Protect Your Right to Compensation: If you’ve developed a meningioma after using Depo-Provera®, you could be eligible for compensation. This may cover medical expenses, lost wages, pain and suffering and more.
  • Act Quickly to Protect Your Rights – Statutes of limitations impose strict deadlines. Delaying action could jeopardize your legal claim.
  • Get a Free Consultation Today – Contact us now to confidentially discuss your case and explore your legal options with our experienced team.

depo provera lawsuit, depo shot side effects

Possible 5.6x higher risk of meningioma with Depo-Provera® use.

Recent Study Links Depo-Provera® to Meningioma

Depo-Provera® is a hormonal birth control method delivered via injection every three months. It contains medroxyprogesterone acetate, a synthetic form of progesterone, and works by preventing ovulation and changing the uterine lining to reduce the chances of pregnancy.

depo provera birth control shot side effects

Key Information About Depo-Provera® You Need to Know

  • Purpose: Depo-Provera® is a trusted, long-lasting contraceptive designed to prevent pregnancy effectively.
  • Administration: It’s administered through an intramuscular injection in the arm or buttock every 12 weeks, ensuring consistent protection.
  • Effectiveness: When used as directed, it is over 99% effective in preventing pregnancy, offering reliable peace of mind.
  • Popularity: This method is favored by millions of women globally for its convenience and highly dependable results.

A recent study published in the British Medical Journal in March 2024 revealed concerning findings about Depo-Provera®, a widely trusted contraceptive.

The study indicates a potential link between prolonged use of Depo-Provera® and an increased risk of brain tumors, specifically meningiomas.

Women who have used Depo-Provera for over a year may face a significantly higher risk of developing these tumors. If you or a loved one has been diagnosed with a brain tumor after using Depo-Provera®, it is crucial to act now.

Contact The Yost Legal Group to learn more about the Depo Provera litigation. Contact us for a FREE, no-obligation consultation today.

The experienced defective products attorneys at The Yost Legal Group are here to support you. We are helping women across the U.S. file dangerous drug lawsuits and seek justice. Call us today at [Phone Number] for a free consultation. Don’t wait—your health and rights matter.

Key Findings on Depo-Provera® and Meningioma Risk

A new study reveals significant findings about the connection between Depo-Provera® and intracranial meningiomas. Here’s what you need to know:

  • Higher Risk Identified: Women who used Depo-Provera® for over a year faced a 5.6x increased risk of developing intracranial meningiomas compared to women who did not use it.
  • Reliable Data: The analysis was conducted on medical records from over 100,000 women through the French National Health Data System.
  • Long-Term Use Concerns: Risks were significantly higher among women who used Depo-Provera® for extended periods, pointing to potential dangers with prolonged use.
  • Specific to Depo-Provera®: Other progestogens, such as progesterone or levonorgestrel intrauterine systems, did not show an increased risk, underlining a unique concern with Depo-Provera®.

Key Implications of the Depo Side Effects Findings

  • Substantial Risk Increase: The study reveals a 5.6-fold increase in the risk of meningioma linked to the use of Depo-Provera®, underscoring a significant and alarming association.
  • Prolonged Use is Riskier: Long-term users face an escalated risk, highlighting the critical role duration plays in user vulnerability.
  • Insufficient Awareness: Many women may have been exposed to this elevated risk without proper disclosure or warnings.
  • Call for Immediate Regulatory Action: These findings signal an urgent need for regulatory agencies to reassess the safety of Depo-Provera®, implement additional warnings, and evaluate potential restrictions.

Your Legal Rights After a Meningioma Diagnosis

Pharmaceutical companies must prioritize the safety of their products and fully inform consumers about any potential risks associated with their drugs.

If you’ve been diagnosed with a meningioma after using Depo-Provera®, understanding Pfizer Inc.’s responsibilities as the drug’s manufacturer is key.

Failures to identify and disclose the risk of meningiomas early in Depo-Provera’s market lifecycle may have caused significant harm to consumers. It’s critical to know your legal rights and take action now.

Filing a Depo Provera lawsuit is the first step toward seeking justice. Contact The Yost Legal Group at 1-410-659-6800 for a free consultation.

Our experienced Depo Provera lawyers are here to provide guidance, support, and fight for justice on your behalf. Don’t wait—your path to justice could begin today.

Potential Failure to Properly Test the Product

  • Insufficient Research: There may have been a lack of thorough studies to assess long-term neurological effects.
  • Ignored Warnings: Early reports of adverse effects might have been overlooked, raising concerns about due diligence.

Possible Failure to Provide Adequate Warnings

  • Misleading Representations: Marketing efforts could prioritize benefits while downplaying serious risks, potentially putting consumers at risk.

Market Effects of Depo-Provera®

  • Failure to Report Adverse Events: Evidence suggests a possible delay in the timely reporting of meningioma cases linked to the use of Depo-Provera®.
  • Insufficient Action on Emerging Evidence: Reports point to a lack of prompt updates to warnings or further research being conducted to address the newly identified risks.

The Yost Legal Group Will Protect Your Rights

If you or a loved one have experienced adverse effects, you may have a claim against the drug manufacturer. Contact The Yost Legal Group at 1-410-659-6800 for a free consultation. Our trusted team is here to provide guidance and advocate for your rights. We will file a Depo Provera lawsuit on your behalf.

Free case evaluations are now available for women who developed meningioma after using Depo-Provera®. Contact us today to explore your legal options and seek the justice you deserve.

New York Times Finally Covers Hair Relaxer Litigation

After 8,000 Hair Relaxer Lawsuits Filed, Mainstream Media Pay Attention to Cancer Risk

The Hidden Dangers of Hair Relaxers for Black Women Exposed

Earlier this month, on June 13, 2024, New York Times Magazine contributing writer Linda Villarosa published “The Disturbing Truth About Hair Relaxers.” Her expansive 6,300-word article was the ripe fruit born from over a year of research about hair relaxer lawsuits.

She interviewed dozens of scientists, government officials, legal experts, and, most importantly, hair relaxer users. Her findings, while shocking to some, were no surprise to us here at The Yost Legal Group.

We have been covering the hair relaxer litigation for two years. Unfortunately, we are all too familiar with the dangers, cancers, and deaths caused by chemical hair straighteners.

The sub-head continues: “They’ve been linked to reproductive disorders and cancers. Why are they still being marketed so aggressively to Black women?”

The easy answer is “Money.” Cosmetics companies like Avlon, L’Oréal, and Revlon have made hundreds of billions of dollars on the heads of Black women without any regard for the effects upon people’s lives.

Higher Uterine Cancer Risk Linked to Hair Straightening Chemicals, NIH Study Reveals

Hair Straighteners Linked to Uterine Cancer in Black Women

Women who used hair straighteners (mostly Black) were 2.5 times more likely to develop uterine cancer. Black women are more than twice as likely to die from uterine cancer than other racial and ethnic groups studied in 2022 by The Journal of the American Medical Association Oncology.

All peer-reviewed studies we have seen show that chemical hair relaxers and straighteners are carcinogenic, yet cosmetics companies continue to market and sell them. It is time to hold them accountable.

Have you been diagnosed with endometrial cancer (not to be confused with endometriosis), non-serous ovarian cancer, or uterine cancer? Have you used chemical hair relaxers or chemical hair straighteners regularly for years? Contact The Yost Legal Group today at 410-659-6800.

Our lawyers for personal injury will help you understand your rights to file a hair relaxer lawsuit. If you used a dark and lovely relaxer and were diagnosed with any of these cancers, we can file a dark and lovely lawsuit on your behalf.

There is a direct connection between hair relaxers and cancer. Click here for hair relaxer lawsuit update information.

Urgent Warning for Black Women Using Hair Straighteners

If you have never used chemical hair relaxers or lived with someone who did, it might be easy to underestimate how prevalent they are among Black women.

According to a 2019 study published by the Journal of Exposure Science & Environmental Epidemiology (and cited in Villarosa’s New York Times Magazine article), 89% of Black women studied reported having used chemical hair relaxers/straighteners at least once.

In 2011, the United States hair-relaxer market generated $71 million just from sales to salons and other professionals. That revenue dropped to $30 million by 2021. However, those figures do not account for the many products sold off-the-shelf directly to consumers.

If you have been diagnosed with uterine cancer and have used hair relaxers regularly, you should consider filing a product liability lawsuit. The toxic chemicals in chemical hair straightening products increase your risk of cancer.

Although the harmful chemicals in these products were known to be carcinogenic, manufacturers continued to use them in their hair products. Multiple studies show the risk of developing uterine cancer with prolonged use of hair straighteners or relaxer products.

Urgent Warning for Black Women Using Hair Straighteners

Hold Cosmetics Companies Accountable for Carcinogenic Hair Products

Hair Relaxer Brands Linked to Reproductive-Organ Cancers:

·     African Pride

·     Avlon

·     Bantu

·     Carson

·     Dark and Lovely

·     Just for Me

·     L’Oréal

·     ORS Olive Oil

·     Revlon

·     Strength of Nature

Hair-straightening products have been on the market since the 1950s. In many families, brand loyalty has become a tradition. Mothers passed their products onto their daughters, who would eventually pass the products onto their own daughters, and so on and so forth.

Some women have decades of chemical hair relaxer use. The blatant disregard for the health and well-being of women of color by these manufacturers is evident. Now, a light is shining on the truth.

Higher Uterine Cancer Risk Linked to Hair Straightening Chemicals, NIH Study Reveals

A recent study from the National Institutes of Health (NIH) has found that women who use chemical hair straightening products face a higher risk of developing uterine cancer than those who do not use these products.

The research, which drew data from 33,497 U.S. women aged 35-74 participating in the Sister Study, highlighted an increased risk, particularly among Black women, who reportedly use these products more frequently.

According to the findings, women who used hair straighteners more than four times in the previous year were more than twice as likely to develop uterine cancer compared to those who did not use the products.

Notably, the study did not find any associations between uterine cancer and other hair products such as dyes, bleach, highlights, or perms.

Key Findings from the Study:

  • Women who never used hair straighteners had a 1.64% chance of developing uterine cancer by age 70.
  • Frequent users (more than four times a year) faced a risk that increased to 4.05%.
  • During nearly 11 years of follow-up, 378 uterine cancer cases were diagnosed among the participants.

Dr. Alexandra White, head of the NIEHS Environment and Cancer Epidemiology group and the study’s lead author, emphasized the significance of these findings. “This doubling rate is concerning. However, it is important to put this information into context—uterine cancer is a relatively rare type of cancer.”

Despite accounting for about 3% of all new cancer cases, uterine cancer remains the most common cancer of the female reproductive system, with an estimated 65,950 new cases in 2022.

Alarmingly, studies indicate that the incidence rates of uterine cancer have been rising in the United States, especially among Black women.

This study underscores the importance of further research and awareness about the potential risks associated with chemical hair straightening products, particularly within communities that use these products more frequently.

Holding Cosmetics Companies Accountable for Product Safety

As the awareness of the potential risks associated with chemical hair relaxers continues to grow, it is crucial for individuals, especially Black women, to educate themselves about the products they use.

Seeking alternative hair straightening methods that do not contain harmful chemicals can help reduce the risk of developing serious health issues. Additionally, holding cosmetics companies accountable for the safety of their products is essential in ensuring the well-being of consumers.

By staying informed and advocating for safer hair care options, individuals can protect themselves and their loved ones from the dangers linked to chemical hair relaxers.

This prevalence over many decades greatly explains the 8,000+ cases that people have filed so far. In the Hair Relaxers Marketing, Sales Practices, and Products Liability Litigation (MDL-3060) in the United States Judicial Panel of Multidistrict Litigation docket.

The Hidden Dangers of Hair Relaxers for Black Women Exposed

It is nice to see a mainstream media organization like The New York Times finally give this cause the attention it deserves. Hair products that cause cancer should be removed from the market.

Black women have been suffering from preventable endometrial, non-serous ovarian, and uterine cancers likely caused by their chemical hair relaxers for far too long without proper recognition.

If you used chemical hair relaxers or chemical hair straighteners regularly and were diagnosed with endometrial cancer (not to be confused with endometriosis), non-serous ovarian cancer, or uterine cancer, call The Yost Legal Group.

We will file a hair relaxer lawsuit to seek financial compensation for you and your family. Our attorneys for personal injury will fight to seek a hair relaxer settlement.

Our experienced hair relaxer lawyers will work to help you get the justice you deserve. Call or text us at 410-659-6800 for a free consultation.

The Link Between Hair Relaxers and Uterine Cancer

Have you or a loved one been diagnosed with uterine cancer, endometrial cancer, or non-serious ovarian cancer? It may be related to the over-the-counter use of chemical hair relaxers.

The long-term use of these products is linked to an increased risk of certain types of cancers in women. At The Yost Legal Group, we are here to help you navigate this difficult situation and explore your legal options.

Read on to learn more about how hair relaxers could impact your health and what steps you can take.

We will help determine if your use of hair straighteners caused your cancer.

Hair Relaxer Lawsuits filed by The Yost Legal Group, Baltimore, MD

 

The Disturbing Truth About Hair Relaxers and Cancer Risk: What Women Should Know

Chemical hair relaxers have been popular for women looking to straighten their hair for many years. However, recent studies have shown a concerning link between the use of these products and an increased risk of:

– uterine cancer

– endometrial cancer

– non-serous ovarian cancer.

The chemicals in many hair relaxers have been found to disrupt hormone levels in the body, potentially leading to these types of cancers over time.

Have you been using chemical hair relaxers for an extended period and received a cancer diagnosis? Speaking with a Hair Relaxer Attorney at The Yost Legal Group is essential.

Some of these products contain chemicals like:

  • parabens
  • nitrosamines
  • bisphenol A (BPA)
  • metals
  • formaldehyde

These harmful chemicals can cause serious health problems, like certain types of cancer, such as uterine and ovarian cancer.

When you straighten your hair, your scalp absorbs these chemicals instead of them just sitting on your hair. These treatments can be harsh and may cause burns or lesions on your scalp. This can make it easier for harmful substances to enter your body and bloodstream.

One chemical to be particularly mindful of is formaldehyde, a substance notorious for its toxicity and cancer-causing potential. Next time you consider getting your hair straightened, remember that the risks might extend beyond just a bad hair day.

Hair straightener cancer includes uterine cancer, endometrial cancer, or non-serious ovarian cancer.

Stay informed and take care when choosing hair treatments. Your health is worth more than straight hair!

Dark and lovely lawsuit and Olive Oil lawsuit hair relaxers

 

From Straight Hair to Serious Health Concerns: The Cancer Risk of Chemical Relaxers

Our team handles product liability cases and can help you determine if your cancer diagnosis may be related to using these harmful products.

You may be eligible to file a hair relaxer lawsuit against the manufacturers of these hair relaxers and seek compensation for your medical expenses, lost wages, pain and suffering, and other damages.

You can click here to see many of the over-the-counter hair relaxers that are linked to causing cancer. Knowing which hair relaxers cause cancer is an important step. Many women have filed Dark and Lovely lawsuits and Olive Oil hair relaxer lawsuits.

It is crucial for women who have been diagnosed with uterine cancer or related conditions to understand their legal rights and options. You can get the guidance and support you need during this challenging time by contacting The Yost Legal Group.

Our experienced hair relaxer cancer lawyers will review your case thoroughly and work tirelessly to hold responsible parties accountable for any harm caused by their products.

Don’t hesitate to reach out by calling 1-800-967-8529. Your cancer diagnosis may be connected to the use of chemical hair relaxers. If you qualify, we will file a hair relaxer lawsuit.

In addition to seeking legal representation, it is also essential for women who have used chemical hair relaxers in the past to prioritize their health moving forward.

Reconsidering Hair Relaxers: The Alarming Link Between Straighteners and Cancer

Consider switching to natural alternatives or avoiding hair straightening treatments to reduce exposure to potentially harmful chemicals.

Regular check-ups with your healthcare provider can also help catch potential health issues early on.

February 27, 2024, Hair Relaxer Lawsuit Update

At this time, over 8,200 cases are pending in the Multi-District Litigation. Document production and review are extremely important in large litigations such as this.

The Honorable Paul Grimm (retired) was hired as the Special Master for electronic discovery in this litigation.

In this role, he has been assigned to use his legal expertise to review and debrief complex issues and oversee other technical matters as assigned by the Judge.

More African American women have a higher risk of developing uterine cancer from chemical hair straightening products

 

Uterine Cancer and Hair Straighteners

Your health should always come first, especially when faced with a serious diagnosis like uterine cancer. The National Institutes of Health and the National Cancer Institute have warned women of the risks associated with hair straighteners or relaxers.

More African American women have a higher risk of developing uterine cancer from chemical hair straightening products.

If you think chemical hair relaxers caused your cancer, contact The Yost Legal Group for help. We will file a hair relaxer cancer lawsuit on your behalf. Filing a lawsuit will send a strong message to the manufacturers of these dangerous products.

At The Yost Legal Group, our hair relaxer lawyers are dedicated to helping women. Let us work to seek justice and compensation for harm caused by these dangerous products.

Remember that you are not alone in this fight, and we are here to advocate for your rights every step of the way. Filing a hair straightener lawsuit is the first step toward seeking justice.

To learn more, go to https://www.yostlaw.com/hair-relaxing-products-linked-to-uterine-cancer-lawsuits/

The Yost Legal Group is representing women nationwide in filing hair relaxer lawsuits. As a leading personal injury law firm, we handle all types of product liability, birth injury, severe injury, and defective medical device cases.

If you have questions, we will help you find answers.

The Yost Legal Group, personal injury lawyers who fight for justice.